Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (T R cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs, which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4 + CD25 + T R cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.

Bibliography

Pasare, C., & Medzhitov, R. (2003). Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells. Science, 299(5609), 1033–1036.

Authors 2
  1. Chandrashekhar Pasare (first)
  2. Ruslan Medzhitov (additional)
References 30 Referenced 1,582
  1. 10.1038/90609
  2. 10.1038/35100529
  3. 10.1016/S0092-8674(00)80412-2
  4. 10.1101/SQB.1989.054.01.003
  5. 10.1038/ni712
  6. 10.1038/32588
  7. 10.1038/ni0901-816
  8. 10.4049/jimmunol.167.3.1137
  9. 10.1016/S0092-8674(00)80856-9
  10. 10.1146/annurev.immunol.18.1.423
  11. 10.1084/jem.184.2.387
  12. 10.1002/eji.1830260730
  13. 10.1084/jem.188.2.287
  14. 10.1093/intimm/10.12.1969
  15. Materials and methods are available as supporting material on Science Online.
  16. C. Pasare R. Medzhitov unpublished observations.
  17. 10.1084/jem.189.4.615
  18. 10.1126/science.282.5396.2085
  19. 10.1038/35047123
  20. 10.4049/jimmunol.166.9.5688
  21. 10.1146/annurev.immunol.14.1.179
  22. Onizuka S., et al., Cancer Res. 59, 3128 (1999). / Cancer Res. by Onizuka S. (1999)
  23. 10.1006/smim.1997.0100
  24. T. Kishimoto J. Autoimmun. 5 Suppl A 123 (1992). (10.1016/0896-8411(92)90027-N)
  25. Samoilova E. B., J. Immunol. 161, 6480 (1998). (10.4049/jimmunol.161.12.6480) / J. Immunol. by Samoilova E. B. (1998)
  26. 10.1073/pnas.95.14.8222
  27. 10.1093/intimm/10.5.703
  28. 10.4049/jimmunol.164.9.4878
  29. 10.1084/jem.193.4.471
  30. We thank A. Rudensky G. Barton E. Kopp and A. Unnifor helpful discussions; S. Akira for the gift of MyD88 TLR2 and TLR4 knockout mice; and G. Dranoff for the gift of Flt3 ligand–expressing cells. This research was supported by the Howard Hughes Medical Institute grants from NIH and a Searle Scholarship to R.M.
Dates
Type When
Created 22 years, 6 months ago (Feb. 13, 2003, 5:06 p.m.)
Deposited 1 year, 7 months ago (Jan. 9, 2024, 11:28 p.m.)
Indexed 4 days, 5 hours ago (Aug. 23, 2025, 9:52 p.m.)
Issued 22 years, 6 months ago (Feb. 14, 2003)
Published 22 years, 6 months ago (Feb. 14, 2003)
Published Print 22 years, 6 months ago (Feb. 14, 2003)
Funders 0

None

@article{Pasare_2003, title={Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells}, volume={299}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.1078231}, DOI={10.1126/science.1078231}, number={5609}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Pasare, Chandrashekhar and Medzhitov, Ruslan}, year={2003}, month=feb, pages={1033–1036} }